SIM
EVOK

Spark Investment Management’s Evoke Pharma EVOK Stock Holding History

Spark Investment Management’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-112
Closed -$24K – 612
2019
Q1 		$24K Sell
112
-21
-16% -$7.16K ﹤0.01% 624
2018
Q4 		$47K Buy
+133
New +$49.2K ﹤0.01% 613

Other funds holding EVOK

SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Spark Investment Management's EVOK Position: Q2 2019 in Review

Spark Investment Management sold out of Evoke Pharma (EVOK) in Q2 2019, closing a stake of 112 shares — an estimated $24K sold.

Spark Investment Management first reported a position in EVOK in Q4 2018 and held it in 2 quarters. The position peaked at $47K in Q4 2018. 19 funds tracked by Wall St. Rank hold EVOK as of Q2 2019.

  • Spark Investment Management reported no remaining Evoke Pharma position as of Q2 2019 after selling out during the quarter.
  • Spark Investment Management sold 112 Evoke Pharma shares in Q2 2019, an estimated $24K.
  • Spark Investment Management first reported a position in Evoke Pharma in Q4 2018 and held it in 2 quarters.
  • Spark Investment Management's Evoke Pharma position peaked at $47K in Q4 2018.
  • 19 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.